Beximco Pharmaceuticals PlcBeximco Pharmaceuticals PlcBeximco Pharmaceuticals Plc

Beximco Pharmaceuticals Plc

No trades
No trades

Compare with Beximco Pharmaceuticals Plc


Market capitalization
‪65.04 B‬BDT
19.39BDT
‪6.94 B‬BDT
‪49.12 B‬BDT
‪431.77 M‬
Beta (1Y)
0.61
Next report date
Report period
EPS estimate
Revenue estimate
Employees (FY)
‪1.22 K‬
Change (1Y)
+101+9.00%
Revenue / Employee (1Y)
‪40.16 M‬BDT
Net income / Employee (1Y)
‪5.68 M‬BDT

Details


CEO
Iqbal Ahmed
Headquarters
Dhaka
Founded
1976
IPO date
Oct 21, 2005
ISIN
BD0453BXPH04
FIGI
BBG000C2D3N5
Identifiers
ISIN BD0453BXPH04
CFI code
ESVUFR
Beximco Pharmaceuticals PLC engages in the business of manufacturing and marketing generic pharmaceuticals formulation products covering a wide range of therapeutic categories. Its products include solid, liquid, cream, and ointment, suppositories, metered dose inhaler, dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company was founded by Ahmed Sohail Fasihur Rahman and Ahmed Salman Fasiur Rahman in 1976 and is headquartered in Dhaka, Bangladesh.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of BXPHARMA is 145.80 BDT — it has increased by 0.55% in the past 24 hours. Watch Beximco Pharmaceuticals Plc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on DSEBD exchange Beximco Pharmaceuticals Plc stocks are traded under the ticker BXPHARMA.
BXPHARMA stock has fallen by −0.88% compared to the previous week, the month change is a −2.80% fall, over the last year Beximco Pharmaceuticals Plc has showed a 23.66% increase.
We've gathered analysts' opinions on Beximco Pharmaceuticals Plc future price: according to them, BXPHARMA price has a max estimate of 260.92 BDT and a min estimate of 142.01 BDT. Watch BXPHARMA chart and read a more detailed Beximco Pharmaceuticals Plc stock forecast: see what analysts think of Beximco Pharmaceuticals Plc and suggest that you do with its stocks.
BXPHARMA reached its all-time high on Oct 6, 2021 with the price of 255.40 BDT, and its all-time low was 30.59 BDT and was reached on May 19, 2014. View more price dynamics on BXPHARMA chart.
See other stocks reaching their highest and lowest prices.
BXPHARMA stock is 1.44% volatile and has beta coefficient of 0.61. Track Beximco Pharmaceuticals Plc stock price on the chart and check out the list of the most volatile stocks — is Beximco Pharmaceuticals Plc there?
Today Beximco Pharmaceuticals Plc has the market capitalization of ‪65.04 B‬, it has decreased by −1.59% over the last week.
Yes, you can track Beximco Pharmaceuticals Plc financials in yearly and quarterly reports right on TradingView.
Beximco Pharmaceuticals Plc is going to release the next earnings report on Sep 2, 2026. Keep track of upcoming events with our Earnings Calendar.
BXPHARMA net income for the last quarter is ‪2.22 B‬ BDT, while the quarter before that showed ‪2.36 B‬ BDT of net income which accounts for 0.00% change. Track more Beximco Pharmaceuticals Plc financial stats to get the full picture.
Yes, BXPHARMA dividends are paid annually. The last dividend per share was 4.75 BDT. As of today, Dividend Yield (TTM)% is 0.00%. Tracking Beximco Pharmaceuticals Plc dividends might help you take more informed decisions.
Beximco Pharmaceuticals Plc dividend yield was 5.52% in 2025, and payout ratio reached 30.53%. The year before the numbers were 3.45% and 30.61% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 9, 2026, the company has ‪1.22 K‬ employees. See our rating of the largest employees — is Beximco Pharmaceuticals Plc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Beximco Pharmaceuticals Plc EBITDA is ‪13.42 B‬ BDT, and current EBITDA margin is 23.26%. See more stats in Beximco Pharmaceuticals Plc financial statements.
Like other stocks, BXPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Beximco Pharmaceuticals Plc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Beximco Pharmaceuticals Plc technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Beximco Pharmaceuticals Plc stock shows the buy signal. See more of Beximco Pharmaceuticals Plc technicals for a more comprehensive analysis.